|
Karyotype
|
88 chromosomes; t(2;5)(p23;q35) translocation
|
|
Antigen Expression
|
Monocyte Marker: CD163+
Lymphoid Marker: CD45-
Progenitor Markers: CD10-, CD34-
Activation Markers: CD30+, CD25+, CD70+, CD71+, CD80-, HLA-DR+, CD45-
T-Cell Markers: CD2-, CD3-, CD4-, CD5+, CD7-, CD8-
B-Cell Markers: CD19-, CD20-, CD21-, CD22-
Myelomonocytic Markers: CD11b-, CD11c-, CD13-, CD14-, CD15-, CD33-
|
|
Receptor Expression
|
CFS-1 expressed
IL-1-R, IL-2-Rα, IL-6-R, TNFα-R, & c-fms expressed
Surface Receptors: Fc, IgMEAC, IgGEA, & E not expressed
|
|
Oncogene
|
c-fms (proto-oncogene), bcl-6+(c-onc)
|
|
Genes Expressed
|
Fusion gene NPM-ALK (p80)+
anaplastic lymphoma kinase (ALK)+
Ig, not expressed
|
|
Comments
|
The cells are surface Ig negative (sIG-).
The cells are non-specific esterase, acid phosphatase and oil red O positive.
The cells are periodic acid Schiff negative.
These cells phagocytose Candida albicans and latex particles.
The cells are reported to be very weakly E - rosette positive.
ATCC confirmed this cell line is negative for the presence of Epstein-Barr viral DNA sequences via PCR.
|